Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

3 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

6 recruiting2 with results

Enrollment Performance

Analytics

N/A
12(70.6%)
Phase 4
3(17.6%)
Phase 1
2(11.8%)
17Total
N/A(12)
Phase 4(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT04996511Not ApplicableRecruiting

Day Case Colectomy: Optimizing Short Stay-surgery.

Role: lead

NCT05005117Not ApplicableActive Not Recruiting

Laparoscopic Approach for Emergency Colon Resection

Role: lead

NCT06633146Not ApplicableRecruiting

Stroke Rehabilitation Utilizing Therapeutical Methods Designed for Nature Environments

Role: lead

NCT05898542Not ApplicableRecruiting

Nature-based Therapies in Stroke Rehabilitation

Role: lead

NCT04151693Not ApplicableRecruiting

Health Psychological Group Rehabilitation for Patients With Chronic Fatigue Syndrome (ME/CFS)

Role: lead

NCT05025319Active Not Recruiting

Optimization of Bedside Chest X-rays Taken in the Intensive Care Unit by Using Current Software-based Techniques

Role: lead

NCT04564105Not ApplicableCompleted

Simulation Training and Teamwork Concerning Intubation on the Icu

Role: lead

NCT04637438Not ApplicableRecruiting

Fecal Microbiota Transplantation in Postoperative Crohn's Disease

Role: collaborator

NCT03732131Recruiting

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Role: lead

NCT02464709Phase 4Completed

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Role: lead

NCT03561532Not ApplicableUnknown

Fecal Transplantation in Ulcerative Colitis

Role: lead

NCT03391817Not ApplicableUnknown

FAECAL MICROBIOTA TRANSPLANTATION IN OBESITY

Role: lead

NCT02367547Phase 1Unknown

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Role: lead

NCT03561519Not ApplicableCompleted

FMT in the Treatment of IBS

Role: lead

NCT02685592Phase 4Completed

Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream

Role: lead

NCT03306810Not ApplicableUnknown

Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service

Role: lead

NCT02862197Unknown

Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients

Role: lead

NCT01893203Phase 4Completed

Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)

Role: lead

NCT02149342Phase 1Completed

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Role: lead

NCT02275650Not ApplicableCompleted

The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter

Role: lead

All 20 trials loaded